Home / Stocks / BAX

Baxter International (BAX, Health Care Equipment) Stock Valuation & Fair Value Trading above fair value

Baxter International (BAX, Health Care Equipment) trades at a blended P/E of 12.5, about 15% below its historical normal valuation, with a forward growth estimate of 1.2% and a PEG of 10.80. Analysts' one-year estimates have been hit 18% of the time.

DATA AS OF 2026-08-21
Blended P/E
12.5
Normal P/E
14.7
PEG
10.80
Fwd growth
1.2%
Div yield
0.1%
RSI (14)
56.4
Neutral

The Street vs SeerForecast

Wall Street's mean price target for BAX is $28.73 across 11 analysts, 9.1% above the current price. The average analyst rating is Hold. Our SeerForecast read of the same stock, formed without analyst targets: trading above fair value. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from fairly valued (2026-06-03) to trading above fair value (2026-08-21).

Price and rating by weekClose moved +44.2 percent from 2026-06-03 to 2026-08-17, with 1 rating change over 21 recorded weeks.2026-06-03: Fairly valued, close 18.54 (recalculated)2026-06-10: Fairly valued, close 20.31 (recalculated)2026-06-14: Fairly valued, close 20.86 (recalculated)2026-06-16: Fairly valued, close 20.46 (recalculated)2026-06-21: Fairly valued, close 19.89 (recalculated)2026-07-02: Fairly valued, close 22.65 (recalculated)2026-07-06: Fairly valued, close 22.58 (recalculated)2026-07-09: Fairly valued, close 22.46 (recalculated)2026-07-12: Fairly valued, close 22.62 (recalculated)2026-07-13: Fairly valued, close 22.57 (recalculated)2026-07-14: Fairly valued, close 21.80 (recalculated)2026-07-20: Fairly valued, close 22.07 (recalculated)2026-07-22: Fairly valued, close 21.74 (recalculated)2026-07-25: Fairly valued, close 22.40 (recalculated)2026-07-27: Fairly valued, close 23.34 (recalculated)2026-07-31: Trading above fair value, close 26.16 (recalculated)2026-08-03: Trading above fair value, close 26.162026-08-07: Trading above fair value, close 27.55 (recalculated)2026-08-10: Trading above fair value, close 27.552026-08-14: Trading above fair value, close 26.73 (recalculated)2026-08-17: Trading above fair value, close 26.7319272026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 9.2-38%Fairly valued
2026-06-10P/E 9.3-37%Fairly valued
2026-06-14P/E 9.3-37%Fairly valued
2026-06-16P/E 9.3-37%Fairly valued
2026-06-21P/E 9.3-37%Fairly valued
2026-07-02P/E 10.5-29%Fairly valued
2026-07-06P/E 10.9-26%Fairly valued
2026-07-09P/E 10.9-26%Fairly valued
2026-07-12P/E 10.9-26%Fairly valued
2026-07-13P/E 10.9-26%Fairly valued
2026-07-14P/E 10.9-26%Fairly valued
2026-07-20P/E 11.0-26%Fairly valued
2026-07-22P/E 11.0-26%Fairly valued
2026-07-25P/E 10.9-26%Fairly valued
2026-07-27P/E 10.9-26%Fairly valued
2026-07-31P/E 12.7-14%Trading above fair value
2026-08-03P/E 12.4-16%Trading above fair value
2026-08-07P/E 12.8-13%Trading above fair value
2026-08-10P/E 13.1-11%Trading above fair value
2026-08-14P/E 12.8-13%Trading above fair value
2026-08-17P/E 12.7-14%Trading above fair value
2026-08-21P/E 12.5-15%Trading above fair value ← now

Frequently asked questions

Is Baxter International stock overvalued?

At a blended P/E of 12.5 versus its historical normal P/E of 14.7, Baxter International trades about 15% below its typical valuation, with a PEG of 10.80 on 1.2% forward growth. tickerseer currently rates it trading above fair value.

What is Baxter International's fair value and PEG?

Baxter International trades at a blended P/E of 12.5 against a historical normal P/E of 14.7, a PEG of 10.80, and a forward growth estimate of 1.2%.

Has tickerseer's rating of Baxter International changed?

tickerseer's rating moved from fairly valued (2026-06-03) to trading above fair value (2026-08-21).

What is the analyst price target for Baxter International?

The mean Wall Street price target for Baxter International is $28.73 across 11 analysts, 9.1% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track BAX free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.